Business Description
![ContraFect Corp ContraFect Corp logo](https://static.gurufocus.com/logos/0C0000ANP8.png?14)
ContraFect Corp
NAICS : 325412
SIC : 2834
ISIN : US2123261024
Description
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its DLA product candidate, exebacase, is currently being studied in patients with chronic prosthetic joint infections (PJIs) of the knee due to S. aureus or coagulase-negative Staphylococci, and the next product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa, K. pneumoniae, and A. baumannii, and has demonstrated potent in vivo activity against these pathogens, even against multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.12 | |||||
Equity-to-Asset | -0.63 | |||||
Debt-to-Equity | -0.44 | |||||
Debt-to-EBITDA | -0.09 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 25.8 | |||||
3-Year EPS without NRI Growth Rate | 23.6 | |||||
3-Year FCF Growth Rate | 30.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.77 | |||||
9-Day RSI | 40.15 | |||||
14-Day RSI | 44.01 | |||||
6-1 Month Momentum % | -57.75 | |||||
12-1 Month Momentum % | -98.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.53 | |||||
Quick Ratio | 0.53 | |||||
Cash Ratio | 0.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -45.9 | |||||
Shareholder Yield % | -8553.93 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -130.28 | |||||
ROIC % | -560.14 | |||||
ROC (Joel Greenblatt) % | -1108.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 0.09 | |||||
EV-to-EBITDA | 0.09 | |||||
EV-to-FCF | 0.07 | |||||
Earnings Yield (Greenblatt) % | 1111.11 | |||||
FCF Yield % | -22115.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CFRXQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ContraFect Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -19.27 | ||
Beta | -0.6 | ||
Volatility % | 107.5 | ||
14-Day RSI | 44.01 | ||
14-Day ATR ($) | 0.006223 | ||
20-Day SMA ($) | 0.018413 | ||
12-1 Month Momentum % | -98.98 | ||
52-Week Range ($) | 0.0111 - 1.49 | ||
Shares Outstanding (Mil) | 10.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ContraFect Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ContraFect Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
ContraFect Corp Frequently Asked Questions
What is ContraFect Corp(CFRXQ)'s stock price today?
The current price of CFRXQ is $0.02. The 52 week high of CFRXQ is $1.49 and 52 week low is $0.01.
When is next earnings date of ContraFect Corp(CFRXQ)?
The next earnings date of ContraFect Corp(CFRXQ) is 2024-07-15 Est..
Does ContraFect Corp(CFRXQ) pay dividends? If so, how much?
ContraFect Corp(CFRXQ) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |